Acarbose Treatment and the Risk of Cardiovascular Disease in Type 2 Diabetic Patients: A Nationwide Seven-Year Follow-Up Study

Acarbose Treatment and the Risk of Cardiovascular Disease in Type 2 Diabetic Patients: A Nationwide Seven-Year Follow-Up Study

Objective. To investigate the potential benefits of acarbose treatment on cardiovascular disease (CVD) in patients with type 2 diabetes by using nationwide insurance claim dataset. Research Design and Methods. Among 644,792 newly diagnosed type 2 diabetic patients without preexisting CVD in a natio...

Full description

Bibliographic Details
Main Authors: Chen, Jui-Ming, Chang, Cheng-Wei, Lin, Ying-Chieh, Horng, Jorng-Tzong, Sheu, Wayne H.-H.
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147291/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147291/

Similar Items